Abstract
Introduction

1
In mammals, white adipose tissue (WAT) accumulates at various sites throughout the body. The most important 2 and well-studied fat deposits occur in subcutaneous regions (SC-AT) and in the abdominal cavity surrounding key 3 internal organs like the pancreas and intestines (Zwick et al, 2018) . Other adipose-specific deposits also form 4 around the heart, kidney, prostate in men and mammary glands in women (Zwick et al, 2018) . In addition to WAT, 5 mammals also possess brown adipose tissue (BAT) located in the interscapular and supraclavicular regions,
6
representing less than 5% of the total fat mass (Leitner et al, 2017; Nedergaard et al, 2007; Saito et al, 2009;  postnatally within the BM of long bones extending from below the growth plate through the metaphysis and into 1 the diaphysis (Scheller & Rosen, 2014) . Existence of these two populations remains unconfirmed in humans. Inside 2 the diaphysis of long bone, the number of BM-Ad varies between mouse strains and species, and some strains 3 require pharmacological induction of BM-Ad by drugs such as glucocorticoids and thiazolidinedione (Scheller et 4 al, 2016 ). Yet, human BM-Ad consistently fill 50 to 70% of the bone marrow cavity (Hindorf et al, 2010) . Many 5 studies use bone marrow mesenchymal stromal cells (BM-MSC) differentiated in adipocytes in vitro. However, it 6 is unclear whether these differentiated cells recapitulate the phenotype of mature human primary BM-Ad. These 7 in vitro studies suggest a role for BM-Ad in hematopoiesis regulation (Mattiucci et al, 2018; Naveiras et al, 2009), 8 bone remodeling (Hardaway et al, 2015) and cancer progression (Diedrich et al, 2016; Herroon et al, 2013; Liu et 9 al, 2015; Shafat et al, 2017; Tabe et al, 2017) . These issues highlight that our knowledge of the physiological 10 phenotype of primary BM-Ad remains limited. Using combined lipidomic and proteomic large-scale approaches,
11
we purified and characterized human BM-Ad harvested from the femoral diaphysis of patients undergoing hip 12 surgery with paired subcutaneous adipocytes (SC-Ad) and found that BM-Ad exhibit clearly distinct lipid 13 metabolic features that reveal a new adipocyte sub-type. 
2
After harvesting paired SC-AT and BM-AT from patients undergoing hip replacement surgery, we isolated 3 adipocytes after collagenase digestion (Fig 1A) . In AT from both locations, the vast majority of the space contained 4 large and cohesive mature adipocytes with a unique LD filled with neutral lipids (assessed by Bodipy staining)
5
( Fig 1B) . Mature adipocytes from both locations expressed perilipin 1 (PLIN1) at the surface of the LD (Fig EV1A- 
6
B) and exhibited a very thin cytoplasm rim, a morphological trait expressed by white adipocyte (Fig EV1B) (Cinti, 7 2001) . SC-AT and BM-AT also contained blood vessels highly positive for actin staining and stroma vascular cells 8 at both stromal and perivascular positions ( Fig 1B and Fig EV1A) . Using transmission electron microscopy 9 approach, we observed that both SC-Ad and BM-Ad present in the AT display a large LD surrounded by a very 10 thin cytoplasm with the nucleus located at the cell periphery between the plasma membrane and the LD (Fig 1C) .
11
We performed an enzymatically based digestion protocol to isolate adipocytes from both tissues. After obtaining 12 a population of cells constituted only of adipocytes, our results indicated that our tissue dissociation preserved the 13 morphological identity of the isolated adipocytes. The isolated BM-Ad and SC-Ad shared the same morphology 14 found within the tissues characterized by the presence of a unique and large LD filled with neutral lipids (Fig 1D) .
15
In addition, F-Actin staining showed a similar cytoskeleton architecture between the two types of cells ( Fig 1D) .
16
Taken together, our results demonstrate the BM-AT present in the diaphysis of long bone is composed of cohesive 17 adipocytes that exhibit the morphological appearance of white adipocytes as assessed by their unique LD,
18
surrounded by a thin cytoplasm and a nucleus present at the periphery of the cells. With the caution noted in the 19 introduction, a recent study in mice that used electronic transmission found that BM-Ad exhibit similar rounded 20 morphology with a unique large LD (Robles et al, 2019 ). Yet, a recent report suggested that mouse BM-Ad express 21 some genes related to BAT, including PRDM16 and FOXC2 (Krings et al, 2012) . However, this study used whole 22 tibia extracts, which contain adipocytes and contaminating cells, including myeloid cells and osteoblasts that 23 express PRDM16 and FOXC2, respectively (Kim et al, 2009; Nishikata et al, 2011) . Here, we present an initial 24 morphological characterization of human BM-Ad, where they exhibit traits of white adipocytes that do not clearly 25 distinguish them from "classical" white adipocytes.
adipocytes likely came from food intake. We conclude that BM-Ad lipid composition reflects dietary lipid intake, 1 which is consistent with a prior report in SC-Ad (Hodson et al, 2008) . We then investigated if differences exist in 2 lipid classes between SC-Ad and BM-Ad by comparing all quantified lipid species for one class between the two 3 locations. As shown in Fig 2C, we observed differences in GL content. BM-Ad, in all samples, exhibited a slight 4 increase in TG content with no changes in DG levels. MG content increased (Fig 2C) , which reflected an increase 5 of both saturated and unsaturated major MG species (Fig EV2C) . These results suggest that the hydrolysis of MG 6 is not efficient in BM-Ad. Two additional lipid classes are also increased in BM-Ad compared to SC-Ad, wax 7 esters and sphingosine. Of note, only three sphingosine species were detected. The LC-MS/MS approach we used 8 to quantify the lipid species does not identify cholesterol species, a key lipid species contained in adipocyte LD 9 (Schreibman & Dell, 1975) . Using a colorimetric assay, we found that BM-Ad showed a 1.5-fold increase in free 10 cholesterol content compared to SC-Ad (Fig 2D) . Cholesterol ester was not detected in either sample as we 11 predicted since the vast majority of cholesterol is expressed in a free form in adipocytes (Schreibman & Dell, 12 1975) . Here, we characterize the lipid content in BM-Ad using unsupervised lipidomic approaches. Inter-
13
individual variability suggests that BM-Ad lipid content partially reflects dietary intake as in other adipose depots.
14
Our results demonstrate that intrinsic differences exist between BM-Ad and SC-Ad regarding free cholesterol and
15
MG contents.
17
Proteome of BM-Ad and SC-Ad differentiates adipocytes in lipid metabolic functions
18
We sought to further decipher the metabolic pathways specifically present in BM-Ad, so we conducted a large-
19
scale proteomic analysis on paired SC-Ad and BM-Ad. We detail the data analysis general strategy in Fig EV3A. 
20
After data quality control, 3259 proteins were robustly detected. Interestingly, when we searched for proteins 21 known to be secreted by adipocytes, termed adipokines (Fasshauer & Blüher, 2015) , our dataset did not highlight 22 significant differences between the two types of adipocytes and K-means clustering based on the expression 23 pattern of adipokines did not allow clustering of the samples according to their anatomical location (Fig EV3B) .
24
BM-Ad expressed the adipocyte-specific adipokine, adiponectin, at the same levels as SC-Ad (Fasshauer &
25
Blüher, 2015) (ADIPOQ , Table EV1 ). We obtained similar results for leptin (LEP , Table EV1 ), a hormone 26 predominantly produced by adipocytes (Fasshauer & Blüher, 2015) . These results indirectly assess the quality of 27 cell preparation and their purity.
28
Among the 3259 proteins detected, 612 proteins involved in glucose and lipid metabolism were identified. We
29
performed an unsupervised multivariate analysis focused on these proteins, which clearly demarcated the 4
We uncovered a clear separation of the samples by their location using hierarchical clustering dendrogram (Fig   1   3D ). In BM-Ad, proteins involved in cholesterol transport (apoliproproteins APO-A2, -C1 and -C4) and 2 hydrolysis, such NCEH1 (Neutral Cholesterol Ester Hydrolysis) and LIPA (Lipase A) (Litvinov et al, 2018) , were 3 enriched. This cholesterol-oriented metabolism in BM-Ad is strengthening by the enrichment of several proteins 4 involved in cholesterol biosynthesis and statin pathways (Fig EV3C) . On the opposite, proteins related to lipolysis 5 were down-regulated in BM-Ad compared to SC-Ad in lipoprotein metabolism pathway (Fig 3D) . Surprisingly,
6
the lipases involved in TG hydrolysis LIPE (gene name of HSL) and MGLL (gene name of MAGL) were decreased
7
(1. 19 ± 0.80, p= 0.016 for LIPE and -2.45 ± 0.35 p =0.00024 for MGLL, see Table EV1 ), as well as the Fatty
8
Acid Binding Protein 4 (FABP4), one of the most abundant proteins in adipocytes that participate in maintaining 9 adipocyte homeostasis and regulating lipolysis and adipogenesis (Prentice et al, 2019) . Finally, BM-Ad and SC-
10
Ad exhibited distinct expression patterns of proteins involved AA metabolism and FA metabolism (Fig EV3D-E) .
11
Despite similar morphology and expression pattern of adipokines, our results strongly support that BM-Ad are 12 adipocytes that exhibit a very specific lipid metabolism compared to the "classical" SC-Ad. We uncovered an 13 accumulation of free cholesterol in these cells. This conclusion is supported by unbiased proteomic approaches 14 that indicate a seemingly unidentified cholesterol-oriented metabolism. In contrast to our results, a recent 15 transcriptomic study comparing gene expression of human BM-Ad isolated from the femoral head and SC-Ad
16
show that genes over-represented in human BM-Ad participate in signaling pathways without clear differences in 17 the enzymes involved in lipid metabolism (such as cholesterol metabolism and TG hydrolysis) (Mattiucci et al,
18
2018). In addition, this report found decreased adiponectin expression, which stand in contrast to our current results
19
and another study that identified BM-Ad as an important source of adiponectin (Cawthorn et al, 2014) . We 20 speculate technical issues, such as transcriptomic vs proteomic, and the different sources of BM-AT used may 21 underlie the differences in these findings. We suspect that the specificity of BM-Ad in cholesterol metabolism may 22 reflect their role in supporting BM hematopoiesis (Naveiras et al, 2009; Zhou et al, 2017) . Cholesterol is essential 
25
the main functions of adipocytes, liberating energy reserve stores as TG under times of energy demand, appears 26 downregulated in these cells. This interesting observation is consistent with the absence of a decrease in BM 27 adiposity under energy deficit conditions (Bathija et al, 1979; Cawthorn et al, 2014; Devlin et al, 2010; Tavassoli, 28 1974) . In particular, we observed a critical down-regulation of MAGL expression, a lipase required for the final 29 hydrolysis of MG produced by HSL activation (Zechner, 2015) . As such, MAGL deficiency in mice leads to a 30 concomitant increase in MG levels in AT (Taschler et al, 2011) as observed in BM-Ad. The concomitant decrease 31 of MAGL expression and increase in MG species strongly suggests that MAGL activity may be impaired in BM-
32
Ad compared to SC-Ad.
34
Human primary BM-Ad present a defect in lipolytic activity not recapitulated in in vitro models
35
Due to the potential high impact of this newly described regulation in BM-Ad physiology, we further characterized 36 the lipolytic pathway using Western blot analysis of the three major lipases involved in the consecutive hydrolysis 37 of TG. While we observed no differences in ATGL and HSL expression in BM-Ad compared to paired SC-Ad,
38
we found a sharp decrease (about 5-fold) in MAGL (Fig 4A) . While we found a slight (1.21-fold) decrease in HSL 39 protein expression in our proteomic studies, this result was not reproduced using Western blot analysis. This discrepancy highlights inter-individual variability. We then functionally assayed lipolytic activity using ex vivo 1 approaches on isolated adipocytes. Under basal conditions, we observed reduced glycerol and FFA release in BM-2 Ad compared to SC-Ad (Fig 4B and 4C 
7
A key finding from our study is the profound down-regulation of MAGL expression, which has never been 
12
regulate MAGL expression, this indicates that these cells use the only efficient way to inhibit this specific activity.
13
The slight, but not significant, increase of FFA upon lipolytic stimulation in BM-Ad (Fig 4C) suggests that the 14 lipolysis process is not completely effective in these cells. In mice, a study suggests that rat cBM-Ad (from tail 15 vertebrae) and rBM-Ad (from proximal tibia and femur) are resistant to lipolysis induced by -adrenergic stimuli.
16
This corresponds at the molecular level to a decrease in active phosphorylation of HSL, whereas the levels of 
22
We then focused on the metabolic characteristic of BM-Ad we discovered, so we examined the physiological 23 relevance of in vitro differentiated adipocytes used as the gold standard model for studying the role of BM-Ad.
24
We differentiated human primary BM-MSCs and murine BM-MSC OP9 cell lines in vitro under adipogenic 25 conditions. The murine pre-adipocyte 3T3-F442A served as a control reflecting "classical adipocytes". In all cells, 26 the differentiation process strongly increased TG content (Fig 4D) . In vitro differentiated adipocytes from BM-
27
MSCs exhibited similar levels of basal lipolysis compared to differentiated 3T3-F442A (Fig 4E) (authorization° DC-215-2342) . Briefly, during total hip replacement surgeries, after skin incision, 6 maximus gluteus muscle and external rotators dissection, an osteotomy of the femoral neck was performed which 7 allowed access to the intramedullary canal. While broaching the canal, BM-AT was aspirated cautiously with a 8 soft cannula in the femoral proximal metaphysis and diaphysis before prosthesis placement. All procedures were 9 performed using the same posterior approach. SC-AT were harvested using surgical blade at the incision site in 
12
(Sigma-Aldrich) and 0.5% free fatty acid (FFA-free) bovine serum albumin (BSA) (Sigma-Aldrich) and rapidly 13 carried out to the laboratory (within 1h) where they were processed. The BM-AT that share the same macroscopic 14 aspects compared to SC-AT was dissected from area rich in hematopoietic cells (red marrow). For all the 15 experiments performed in our study, 24 independent samples were used and obtained from 14 men and 10 women
16
(mean age: 66.7 ± 13.9 years and mean body mass index (BMI): 26.8 ± 3.4 kg/m 2 ).
18
Adipocyte isolation.
19
SC-AT and BM-AT were rinsed several times in KRBHA prior to collagenase digestion (250 UI / mL diluted in
20
PBS calcium and magnesium free supplemented with 2% FFA-free BSA (all products were obtained Sigma- 
29
Microscopy Sciences (EMS)) overnight. Fixed tissues were blocked and permeabilized in calcium and magnesium
30
free PBS supplemented with 3% BSA and 0.2% Triton X100 (both obtained from Sigma Aldrich) for 1 h at RT.
31
Tissues were then incubated overnight with a mouse anti PLIN1 serum (Acris Biosystem; 1:10 in calcium and 32 magnesium free-PBS, 3% BSA, 0.2% Triton X-100). The following day the tissues were rinsed 5 times in PBS 33 0.05% Tween-20 and incubated for 2 h with a secondary antiboby coupled with CF488 dye (Biotum) for PLN1 34 staining, rhodamine coupled phalloidin (Thermofisher) for filamentous actin staining and TOPRO3 ®
35
(Thermofisher) for nuclei staining. Z-stack images were acquired using LSM 710 confocal microscope and a 10X 
6
(EMS) and 3% Reynolds lead citrate (Chromalys). Grids were examined with a TEM (Jeol JEM-1400, JEOL Inc) 7 at 80 kV. Images were acquired using a digital camera (Gatan Orius, Gatan Inc, Pleasanton, CA, USA).
9
Confocal microscopy on isolated adipocytes 10 BM-Ad and SC-Ad were isolated as described above. Immediately after isolation, primary adipocytes were 11 embedded in a fibrin gel to maintain cellular integrity. Briefly, 30µl of isolated adipocytes were gently mixed with 12 30µl of a fibrinogen solution (18 µg/mL in 0.9% NaCl buffer, Sigma-Aldrich) and 30µl of thrombin (3 units in
13
30µl of CaCl2 solution, Sigma-Aldrich). Gel polymerization occurs rapidly at 37°C. The gels containing the 14 primary adipocytes were fixed in 4% PFA for 1h and incubated with 10 ng/mL of Bodipy ® 493/503, rhodamine 15 coupled phalloidin and TOPRO3 (all products were obtained from Thermofischer). Samples were examined using
16
LSM 710 confocal microscope and a 40X objective (Zeiss). Maximum intensity projection was performed using
17
Image J software.
19
Lipidomic analysis
20
For the lipidomic and proteomic studies, 4 samples were used (2 men and 2 women, mean age: 67± 7. 4 years;
21
mean BMI: 26.5 ± 3.1 kg/m 2 ). After 3 washes with PBS, isolated adipocytes (400 µl) were mixed 1.5 mL methanol 22 in glass tubes. Sample mixture was then incubated with 5 mL of methyl tert-butyl ether (MTBE ;Sigma-Aldrich)
23
for 1h at RT under gently shaking. After adding 1.2 mL of water, samples were centrifuged for 10 min at 1000 g.
24
Upper phase (containing lipids) was transferred in a new glass tube. Lower phase was re-extracted with 2 volume 25 parts of MTBE: methanol: water (10: 3: 2.5) and samples were centrifuged for 10 min at 1000 g and used for 26 proteomic analyses (see below). Upper phase was collected, combined with the one collected after the first 27 extraction and kept at -80°C for lipidomic analysis. One ml of lipid phase was evaporated under a nitrogen stream.
28
Dried samples were sent to the Harvard mass spectrometry core and were analyzed by their untargeted lipidomics Cholesterol content within isolated adipocytes was measured using cholesterol assay kit (obtained from Abcam-5 ab65390) according to manufacturer recommendations. Briefly, lipids were extracted from isolated adipocytes 6 using MTBE as described above. Free cholesterol and total cholesterol was sequentially quantified using 7 colorimetric method. Optical density was determined at 570 nm with µ-quant spectrophotometer (BioTek 8 Instruments).
10
Proteomic analysis
11
After 3 washes with PBS, proteins from isolated adipocytes (400µl) were purified with 5 mL of MTBE as described 12 in lipidomic analysis section. Lower phase was centrifuged for 10 min at 5000 g at RT and pellet (containing 
25
Peptides were analyzed by nanoLC-MS/MS using an UltiMate 3000 RSLCnano system coupled to a Q-Exactive
26
Plus mass spectrometer (Thermo Fisher Scientific, Bremen, Germany). Five µL of each sample were loaded on a 27 C-18 precolumn (300 µm ID x 5 mm, Thermo Fisher) in a solvent made of 5% acetonitrile and 0.05% TFA and at 28 a flow rate of 20 µL/min. After 5 min of desalting, the precolumn was switched online with the analytical C-18 29 column (75 µm ID x 15 cm, Reprosil C18) equilibrated in 95% solvent A (5% acetonitrile, 0.2% formic acid) and
30
5% solvent B (80% acetonitrile, 0.2% formic acid). Peptides were eluted using a 5 to 50% gradient of solvent B
31
over 300 min at a flow rate of 300 nL/min. The Q-Exactive Plus was operated in a data-dependent acquisition 32 mode with the XCalibur software. MS survey scans were acquired in the Orbitrap on the 350-1500 m/z range with 33 the resolution set to a value of 70000. The 10 most intense ions per survey scan were selected for HCD 34 fragmentation and the resulting fragments were analyzed in the Orbitrap with the resolution set to a value of 17500.
35
Dynamic exclusion was employed within 30 seconds to prevent repetitive selection of the same peptide. Duplicate 36 technical LC-MS measurements were performed for each sample.
cysteines was set as a fixed modification whereas oxidation of methionine and protein N-terminal acetylation were 1 set as variable modifications. Specificity of trypsin digestion was set for cleavage after K or R, and two missed 2 trypsin cleavage sites were allowed. The precursor mass tolerance was set to 20 ppm for the first search and 4.5ppm 3 for the main Andromeda database search. The mass tolerances MS/MS mode was set to 0.5 Da. Minimum peptide 4 length was set to seven amino acids, and minimum number of unique peptides was set to one. Andromeda results
5
were validated by the target-decoy approach using a reverse database at both a peptide and a protein FDR of 1%.
6
For label-free relative quantification of the samples, the "match between runs" option of MaxQuant was enabled 7 with a time window of 0.7min, to allow cross-assignment of MS features detected in the different runs.
8
The "LFQ" metric from the MaxQuant "protein group.txt" output was used to quantify proteins. Missing protein 9 intensity values were replaced by a constant noise value determined independently for each sample as the lowest 10 value of the total protein population. Only proteins identified in at least three samples in the same location (i.e.
11
SC-Ad or BM-Ad) were considered as robustly detected and were used for statistical and bioinformatic analyses.
12
Protein involved in lipid and glucose metabolism were selected using gene analytics software based on their 
26
Imaging System (Biorad). Densitometry quantification was performed using image lab software (v5.2.1; Biorad).
27
Signal intensity was normalized to β-Actin. 
34
The results were normalized to the quantity of total lipids. The histograms represent mean ± SEM, *** p<0. 001 
30
independent experiments (4 independent donors were used for human BM-MSC) and were normalized to the 31 quantity of the total protein content. The histograms represent mean ± SEM, *p<0.05; **p<0.01according to two- 
19
Histograms represent mean ± SEM, * p<0.05 according to two way ANOVA followed by Bonferroni's post-test. 
